Skip to content

Viridian Therapeutics, Inc. VRDN Compensation and benefits

Compensation and benefits at other companies

ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
Arrowhead Research logo
Arrowhead ResearchARWR
BridgeBio Pharma logo
BridgeBio PharmaBBIO
Roivant Sciences logo
Roivant SciencesROIV
Johnson & Johnson logo
Johnson & JohnsonJNJ

Other financials

Income statement

See full
Revenue$141.0K+95.8%
Operating income-$116.2M-23.8%
Net income-$104.9M-20.7%
EPS (diluted)-$1.15-5.5%

Balance sheet

See full
Cash & equivalents$176.3M+51.7%
Total debt$36.8M+59.4%
Total equity$636.0M+5.2%
Total assets$789.0M+19.4%

Cash flow

See full
Operating cash flow-$119.7M-29.1%
CapEx$23.0K-73.3%
Free cash flow-$119.7M-29.0%

Valuation

See full
Market cap$1.91B+82.0%

Profitability

See full
Gross margin36.3%
Operating margin-543.9%-271pp
Net margin-508.5%-254pp
FCF margin-428.4%-214pp

Returns & leverage

See full
Return on equity-58.1%+7.9pp
Debt / equity0.1×0.0×
Current ratio15.1×-4.3×

Where this comes from

Reported directly by Viridian Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.

The official record: Viridian Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Viridian Therapeutics, Inc.'s compensation and benefits.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Viridian Therapeutics, Inc.'s compensation and benefits?
Viridian Therapeutics, Inc. (VRDN) reported compensation and benefits of $8.36M in Q1 2026.
How has Viridian Therapeutics, Inc.'s compensation and benefits changed year-over-year?
Viridian Therapeutics, Inc.'s compensation and benefits increased by 64.1% year-over-year, from $5.1M to $8.36M.
What is the long-term trend for Viridian Therapeutics, Inc.'s compensation and benefits?
Over 5 years (2020 to 2025), Viridian Therapeutics, Inc.'s compensation and benefits has grown at a 58.5% compound annual growth rate (CAGR), from $1.96M to $19.66M.